CN1046411C - 牛皮癣注射液 - Google Patents

牛皮癣注射液 Download PDF

Info

Publication number
CN1046411C
CN1046411C CN94111537A CN94111537A CN1046411C CN 1046411 C CN1046411 C CN 1046411C CN 94111537 A CN94111537 A CN 94111537A CN 94111537 A CN94111537 A CN 94111537A CN 1046411 C CN1046411 C CN 1046411C
Authority
CN
China
Prior art keywords
injection
curing
psoriasic
commercially available
amikacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94111537A
Other languages
English (en)
Other versions
CN1123143A (zh
Inventor
许洪良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN94111537A priority Critical patent/CN1046411C/zh
Publication of CN1123143A publication Critical patent/CN1123143A/zh
Application granted granted Critical
Publication of CN1046411C publication Critical patent/CN1046411C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明是一种牛皮癣注射液，它主要由占总重量35.55～49.55%的灭菌用水、3.26～5.26%的冻干丁胺卡那、36.55～48.55%的林可霉素注射和7.64～13.64%的地塞米松注射液配制而成。具有加工简单、无毒副作用、治愈率高等优点。可用于对皮肤顽症牛皮癣的治疗。

Description

牛皮癣注射液
本发明是一种用于治疗牛皮癣的注射液。
据《中国健康》杂志1992年第2期“牛皮癣能治愈吗”一文介绍，目前治疗牛皮癣的西药有维生素C和安茶俭、维生素K4、维脑路通、灭滴灵、红霉素、蛇毒抗栓酶、银屑灵等；中成药有：复方青黛丸、消银片、银屑灵冲剂、六味地黄丸等。上述药物虽然也能对皮肤顽症牛皮癣起到一定的治疗作用，但效果差，复发率高。如山东淄博人民制药厂生产的银屑灵冲剂，总有效率仅为73.8％。有些药物副作用大，象安茶俭为剧毒药，毒性大；红霉素，有严重的胃肠道反应；银屑灵口服后会出现唇干、口角皲裂口腔炎，孕妇使用还会导致畸胎。
本发明的目的在于提供一种效果好、治愈率高、复发率低、又无毒副作用的牛皮癣注射液。
本发明的牛皮癣注射液包括占总重量35.55～49.55％的灭菌用水、3.26～5.26％的冻干丁胺卡那、36.55～48.55％的林可霉素注射液和7.64～13.64％的地塞米松注射液，经混合、溶化配制而成。
由于本发明的牛皮癣注射液仅由三种市售成药和灭菌用水配制而成，加工简单且无毒副作用；经临床应用94例，痊愈52人(其中病史5年以上的23人)，占55.4％；显效的26人，占27.7％；有效的14人，占14.9％。总有效率为96.8％。
下面通过实施例对本发明作进一步的详细说明。
选用占总重量37％的灭菌用水、5.2％的市售冻干丁胺卡那、47.3％的市售林可霉素注射液和10.5％的市售地塞米松注射液，经混合、溶化配制成牛皮癣注射液。
选用占总重量48％的灭菌用水、3.3％的市售冻干丁胺卡那、40％的市售林可霉素注射液和8.7％的市售地塞米松注射液，经混合、溶化配制成牛皮癣注射液。
选用占总重量40.5％的灭菌用水、4.0％的市售冻干丁胺卡那、45.9％的市售林可霉素注射液和9.6％的市售地塞米松注射液，经混合、溶化配制成牛皮癣注射液。
上述实施例中所用市售林可霉素注射液的浓度为30％、地塞米松注射液的浓度为0.5％。
本发明的牛皮癣注射液经临床94例应用，成人每天肌肉注射一次，每次4.5毫升。痊愈率为55.4％，总有效率为96.8％。

Claims (1)

1、牛皮癣注射液，其特征在于它由占总重量35.55～49.55％的灭菌用水、3.26～5.26％的冻干丁胺卡那、36.55～48.55％的林可霉素注射液和7.64～13.64％的地塞米松注射液，经混合、溶化而制成；其中：林可霉素注射液的浓度为30％，地塞米松注射液的浓度为0.5％。
CN94111537A 1994-12-17 1994-12-17 牛皮癣注射液 Expired - Fee Related CN1046411C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN94111537A CN1046411C (zh) 1994-12-17 1994-12-17 牛皮癣注射液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94111537A CN1046411C (zh) 1994-12-17 1994-12-17 牛皮癣注射液

Publications (2)

Publication Number Publication Date
CN1123143A CN1123143A (zh) 1996-05-29
CN1046411C true CN1046411C (zh) 1999-11-17

Family

ID=5035398

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94111537A Expired - Fee Related CN1046411C (zh) 1994-12-17 1994-12-17 牛皮癣注射液

Country Status (1)

Country Link
CN (1) CN1046411C (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107050060A (zh) * 2017-04-14 2017-08-18 曾仲强 治疗牛皮癣的外用药及药物组合物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LANAT(ENGLAND) V1,(MAR.5) 1988.1.1 powles,A.V.ET."INTRALESI8ONAL INJECTION OF CYCLOSPORIN IN PSORIASIS" *
江西医药 1988.1.1 张水龙等 *
江西医药 1988.1.1 张水龙等;LANAT(ENGLAND) V1,(MAR.5) 1988.1.1 powles,A.V.ET."INTRALESI8ONAL INJECTION OF CYCLOSPORIN IN PSORIASIS" *

Also Published As

Publication number Publication date
CN1123143A (zh) 1996-05-29

Similar Documents

Publication Publication Date Title
CN103191418B (zh) 一种内外治结合治疗口腔溃疡的口含贴片
CN1046411C (zh) 牛皮癣注射液
CN1261105C (zh) 一种复方吡拉西坦脑蛋白水解物制剂及制备方法
CN101156942A (zh) 治疗复发性口腔溃疡及慢性咽炎的药物组合
CN1157145A (zh) 一种治疗弓形虫病的药品及其配方
CN1201769C (zh) 治疗糖尿病、肾病的药物
CN1077117A (zh) 治疗银屑病复方斑蝥软膏的配制方法
Edström Rheumatic fever, its symptoms, prevention and treatment
CN1056283C (zh) 一种治疗脑栓塞后遗症的中药
CN109260297B (zh) 一种用于治疗痔疮的中药组合物及其制备方法
CN1319562C (zh) 一种消炎杀菌的中药制剂及生产方法
CN1047621A (zh) 痔疮灵
CN1380092A (zh) 痔愈散
CN1055409C (zh) 一种治疗复杂性尿系感染的药物
CN102988403A (zh) 用于治疗急性期面瘫的注射药物组合
CN1053577C (zh) 烧烫散
CN1070067C (zh) 治疗尖锐湿疣的药物及其制法
JPS6229529A (ja) 病疾患治療薬製造方法
RU2172634C2 (ru) Способ лечения бронхиальной астмы
CN1287852A (zh) 痔疮丹
CN1060343C (zh) 一种抗感染消炎药物
Nicholls Penicillin in leptospirosis.
CN1352988A (zh) 治疗胃寒的外用中药制剂
CN1160112C (zh) 感冒鼻炎治疗液及其配制方法和应用
CN102846670A (zh) 治疗咬手指癖的生物药剂

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee